Target type: biologicalprocess
The regulated release of ghrelin from a cell. Ghrelin is a 28 amino acid hunger-stimulating peptide hormone. [GOC:cjm, PMID:14610293, Wikipedia:Ghrelin]
Ghrelin secretion is a complex process that involves a series of steps initiated by the presence of an empty stomach. The primary site of ghrelin production is the stomach, specifically within the enteroendocrine cells known as X/A-like cells located in the gastric mucosa. These cells contain the gene encoding preproghrelin, which is processed into ghrelin through a series of enzymatic cleavages.
The process begins with the recognition of specific signals that indicate an empty stomach, such as the presence of low levels of nutrients in the stomach, distension of the stomach wall, or the absence of food-related stimuli. These signals activate a cascade of intracellular signaling pathways, primarily involving G protein-coupled receptors (GPCRs), which ultimately lead to the expression and release of ghrelin.
One of the key signaling pathways involved in ghrelin secretion is the GHSR (growth hormone secretagogue receptor) pathway. This pathway is activated by specific ligands, including ghrelin itself, leading to downstream signaling events that ultimately promote ghrelin release. Other signaling pathways involved include the NPY (neuropeptide Y) pathway and the orexin pathway, which contribute to the regulation of ghrelin secretion.
Once ghrelin is synthesized and processed within the X/A-like cells, it is packaged into secretory vesicles and transported to the cell membrane. These vesicles fuse with the membrane, releasing ghrelin into the bloodstream. Once in circulation, ghrelin travels to its target organs, including the hypothalamus, where it interacts with the GHSR to exert its various physiological effects.
Ghrelin secretion is tightly regulated by several factors, including nutritional status, circadian rhythms, and stress levels. For instance, fasting or prolonged periods without food consumption significantly increase ghrelin levels, while the presence of food in the stomach suppresses ghrelin secretion. Similarly, ghrelin levels fluctuate throughout the day, with higher levels typically observed in the morning before breakfast. Stressful events can also influence ghrelin secretion, often leading to increased levels.
The regulation of ghrelin secretion is essential for maintaining energy balance and regulating appetite. Ghrelin acts as a powerful hunger hormone, stimulating food intake and promoting energy storage. By increasing appetite, ghrelin ensures that the body receives the necessary nutrients for survival. Its role in energy homeostasis is further highlighted by its ability to stimulate the release of growth hormone, which plays a crucial role in promoting growth and development.'
"
Protein | Definition | Taxonomy |
---|---|---|
Growth hormone secretagogue receptor type 1 | A growth hormone secretagogue receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q92847] | Homo sapiens (human) |
Free fatty acid receptor 4 | A free fatty acid receptor 4 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q5NUL3] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
lauric acid | dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil. | medium-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; antibacterial agent; plant metabolite |
12-hydroxy stearic acid | 12-hydroxy stearic acid: structure in first source 12-hydroxyoctadecanoic acid : A hydroxy fatty acid that is stearic acid bearing a hydroxy substituent at position 12. | hydroxyoctadecanoic acid; secondary alcohol | bacterial xenobiotic metabolite; plant metabolite |
16-hydroxypalmitic acid | 16-hydroxyhexadecanoic acid : An omega-hydroxy-long-chain fatty acid that is hexadecanoic acid (also known as palmitic acid) which is substituted at position 16 by a hydroxy group. It is a key monomer of cutin in the plant cuticle. | hydroxypalmitic acid; omega-hydroxy-long-chain fatty acid | plant metabolite |
substance p | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent | |
12-hydroxydodecanoic acid | 12-hydroxylauric acid : A medium-chain fatty acid that is the 12-hydroxylated derivative of lauric acid. | omega-hydroxy-medium-chain fatty acid | human metabolite |
3-hydroxydodecanoic acid | 3-hydroxydodecanoic acid: RN given refers to cpd without isomeric designation 3-hydroxylauric acid : A medium-chain fatty acid that is the 3-hydroxylated derivative of lauric acid; associated with fatty acid metabolic disorders. | 3-hydroxy fatty acid; medium-chain fatty acid | |
l 692429 | L 692429: stimulates release of growth hormone; RN refers to (R)-isomer; structure given in first source | ||
l 163191 | |||
cp 424391 | CP 424391: a growth hormone secretagogue; structure in first source | ||
ricinoleic acid | ricinoleic acid : A (9Z)-12-hydroxyoctadec-9-enoic acid in which the 12-hydroxy group has R-configuration.. ricinoleic acid: RN given refers to (R-(Z))-isomer; structure in Merck Index, 9th ed, #8005 | (9Z)-12-hydroxyoctadec-9-enoic acid | |
linoleic acid | linoleic acid : An octadecadienoic acid in which the two double bonds are at positions 9 and 12 and have Z (cis) stereochemistry. Linoleic Acid: A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed) | octadecadienoic acid; omega-6 fatty acid | algal metabolite; Daphnia galeata metabolite; plant metabolite |
alpha-linolenic acid | linolenate : A polyunsaturated fatty acid anion obtained by deprotonation of the carboxy group of either alpha- or gamma-linolenic acid. linolenic acid : A two-membered subclass of octadecatrienoic acid comprising the (9Z,12Z,15Z)- and (6Z,9Z,12Z)-isomers. Linolenic acids are nutrients essential to the formation of prostaglandins and are also used in making paints and synthetic resins. | linolenic acid; omega-3 fatty acid | micronutrient; mouse metabolite; nutraceutical |
hexarelin | hexarelin: a synthetic growth hormone releasing peptide; structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more potent & stable and less toxic than GHRP-6 | ||
sm 130686 | SM 130686: a growth hormone secretagogue; structure in first source | ||
macimorelin | |||
tabimorelin | tabimorelin: a growth hormone secretagogue; structure in first source | ||
l 162752 | |||
sk&f 110679 | |||
ulimorelin | ulimorelin: ghrelin agonist; an 18-membered macrocycle containing 3 amide bonds and a secondary amine as well as 4 stereogenic centers; belongs to macrocyclic peptidomimetics | oligopeptide | |
gw9508 | GW9508: structure in first source | aromatic amine | |
n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine | N-(3-fluorophenyl)-1-((4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine: a small molecule motilin receptor agonist; structure in first source | acetamides | |
yil 781 | YIL 781: an appetite suppressant and weight loss promoter; structure in first source | ||
tak-875 | biphenyls | ||
nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source | ||
gsk 2334470 | GSK 2334470: a PDK1 inhibitor; structure in first source | indazoles | |
tug-469 | TUG-469: a GPR40 agonist with antidiabetic activity; structure in first source | ||
tug-891 | GPU-028: structure in first source |